Pacira BioSciences, Inc.PCRXNASDAQ
Loading
Year-over-year free cash flow growth rate
Percentile
P31
Within normal range
vs 5Y Ago
-31.5x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -23.69% |
| Q3 2025 | 511.53% |
| Q2 2025 | -65.39% |
| Q1 2025 | -13.23% |
| Q4 2024 | -37.76% |
| Q3 2024 | -3.52% |
| Q2 2024 | 11.63% |
| Q1 2024 | 1.05% |
| Q4 2023 | 11.55% |
| Q3 2023 | 2.37% |
| Q2 2023 | 219.15% |
| Q1 2023 | -65.62% |
| Q4 2022 | -2.48% |
| Q3 2022 | 107.37% |
| Q2 2022 | -21.80% |
| Q1 2022 | 64.49% |
| Q4 2021 | -70.24% |
| Q3 2021 | 141.08% |
| Q2 2021 | 2074.09% |
| Q1 2021 | -103.08% |
| Q4 2020 | 0.75% |
| Q3 2020 | 230.53% |
| Q2 2020 | -4653.88% |
| Q1 2020 | -102.41% |
| Q4 2019 | 27.71% |
| Q3 2019 | -19.07% |
| Q2 2019 | 1298.45% |
| Q1 2019 | -92.20% |
| Q4 2018 | 55.86% |
| Q3 2018 | 9.93% |
| Q2 2018 | 240.68% |
| Q1 2018 | -166.41% |
| Q4 2017 | 244.10% |
| Q3 2017 | -448.83% |
| Q2 2017 | 58.48% |
| Q1 2017 | -128.96% |
| Q4 2016 | 60.29% |
| Q3 2016 | 686.13% |
| Q2 2016 | 86.96% |
| Q1 2016 | -228.61% |